Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Curcuminoids in neurodegenerative diseases.

Kim DS, Kim JY, Han Y.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):184-204. Review.

PMID:
22742420
2.

The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Joshi G, Johnson JA.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):218-29. Review.

3.

Curcumin and neurodegenerative diseases: a perspective.

Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ.

Expert Opin Investig Drugs. 2012 Aug;21(8):1123-40. doi: 10.1517/13543784.2012.693479. Epub 2012 Jun 6. Review.

PMID:
22668065
4.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
5.

Metals, oxidative stress and neurodegenerative disorders.

Jomova K, Vondrakova D, Lawson M, Valko M.

Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Epub 2010 Aug 22. Review.

PMID:
20730621
6.

New therapeutic strategy for Parkinson's and Alzheimer's disease.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. Review.

PMID:
20586718
7.

Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.

Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB.

Neurosignals. 2005;14(1-2):46-60. Review.

PMID:
15956814
8.

An update on pharmacological approaches to neurodegenerative diseases.

Scatena R, Martorana GE, Bottoni P, Botta G, Pastore P, Giardina B.

Expert Opin Investig Drugs. 2007 Jan;16(1):59-72. Review.

PMID:
17155854
9.

Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.

Hashimoto M, Rockenstein E, Crews L, Masliah E.

Neuromolecular Med. 2003;4(1-2):21-36. Review.

PMID:
14528050
10.

Ion channels on microglia: therapeutic targets for neuroprotection.

Skaper SD.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):44-56. Review.

PMID:
21143139
11.

Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP.

Neurotox Res. 2013 Apr;23(3):267-300. doi: 10.1007/s12640-012-9337-4. Epub 2012 Jun 28. Review.

PMID:
22739839
12.
13.

The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.

Campos HC, da Rocha MD, Viegas FP, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):239-50. Review.

PMID:
20874702
14.

In the rush for green gold: Can green tea delay age-progressive brain neurodegeneration?

Mandel SA, Youdim MB.

Recent Pat CNS Drug Discov. 2012 Dec;7(3):205-17. Review.

PMID:
22742421
15.

[Neuroprotective effects of curcumin].

Li Y, Wang P.

Zhongguo Zhong Yao Za Zhi. 2009 Dec;34(24):3173-5. Review. Chinese.

PMID:
20352992
16.

Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.

Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, Stella AG.

Neurochem Res. 2007 Apr-May;32(4-5):757-73. Epub 2006 Dec 27. Review.

PMID:
17191135
17.

Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.

Bar-Or A, Rieckmann P, Traboulsee A, Yong VW.

CNS Drugs. 2011 Sep 1;25(9):783-99. doi: 10.2165/11587820-000000000-00000. Review.

PMID:
21870889
18.

Redox regulation of cellular stress response in neurodegenerative disorders.

Calabrese V, Guagliano E, Sapienza M, Mancuso C, Butterfield DA, Stella AM.

Ital J Biochem. 2006 Sep-Dec;55(3-4):263-82. Review.

PMID:
17274531
19.

Apoptosis modulators in the therapy of neurodegenerative diseases.

Deigner HP, Haberkorn U, Kinscherf R.

Expert Opin Investig Drugs. 2000 Apr;9(4):747-64. Review.

PMID:
11060707
20.

Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.

Jazwa A, Cuadrado A.

Curr Drug Targets. 2010 Dec;11(12):1517-31. Review.

PMID:
20704549
Items per page

Supplemental Content

Write to the Help Desk